News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical revises FY2024 financial forecast, expecting growth in revenue and profit. Core metrics show positive trends. Details on the forecast and reasons for revision provided -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement
Takeda announces enterprise-wide program to support growth and deliver core operating profit margin improvement, focusing on organizational agility and leveraging data, digital, and technology capabilities -
